Outcomes of Elderly Patients Hospitalized with the SARS-CoV-2 Omicron B.1.1.529 Variant: A Systematic Review
- PMID: 36767517
- PMCID: PMC9915911
- DOI: 10.3390/ijerph20032150
Outcomes of Elderly Patients Hospitalized with the SARS-CoV-2 Omicron B.1.1.529 Variant: A Systematic Review
Abstract
The Omicron (B.1.1.529) variant of the severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) had an increased rate of spreading among the general population. Although this virus mutation resulted in milder symptoms, those on the vulnerable side of the population are still in danger of developing severe symptoms. Thus, this systematic review focused on identifying the clinical outcomes of older age patients (>65) that are hospitalized with the SARS-CoV-2 Omicron variant. The research was conducted using four electronic databases (PubMed, Scopus, Web of Science, and ProQuest Central), with a search query in December 2022 that comprised the duration of the COVID-19 pandemic. The inclusion criteria comprised (1) a population of patients older than 65 years, (2) a history of hospitalization for SARS-CoV-2 infection, and (3) infection with Omicron B.1.1.529 variant. The initial search generated 295 articles, out of which six were included in the systematic review, and a total of 7398 patients. The main findings were that when looking at the elderly population, the mortality and hospitalization rates remained high. This is because older people are more vulnerable and have more comorbidities that interfere with the virus's progress. However, there is inconsistency in mortality rates, since the data reported by the included studies had different selection criteria based on the severity of the COVID-19 infection. Although no statistically significant differences were found between the unvaccinated and vaccinated groups, patients who got booster doses of vaccination had a lower likelihood of developing severe symptoms, serving as a protective factor for this population.
Keywords: COVID-19; Omicron variant; SARS-CoV-2 infection; elderly patients.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19.Cochrane Database Syst Rev. 2022 Jun 17;6(6):CD014945. doi: 10.1002/14651858.CD014945.pub2. Cochrane Database Syst Rev. 2022. PMID: 35713300 Free PMC article.
-
Antibody tests for identification of current and past infection with SARS-CoV-2.Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2. Cochrane Database Syst Rev. 2022. PMID: 36394900 Free PMC article.
-
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.Cochrane Database Syst Rev. 2023 Nov 30;11(11):CD015395. doi: 10.1002/14651858.CD015395.pub3. Cochrane Database Syst Rev. 2023. PMID: 38032024 Free PMC article.
-
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.Cochrane Database Syst Rev. 2023 Jan 9;1(1):CD014908. doi: 10.1002/14651858.CD014908.pub2. Cochrane Database Syst Rev. 2023. Update in: Cochrane Database Syst Rev. 2023 May 15;5:CD014908. doi: 10.1002/14651858.CD014908.pub3. PMID: 36622724 Free PMC article. Updated.
Cited by
-
Risk factors for the in‑hospital and 1‑year mortality of elderly patients hospitalized due to COVID‑19‑related pneumonia.Exp Ther Med. 2023 Nov 20;27(1):22. doi: 10.3892/etm.2023.12310. eCollection 2024 Jan. Exp Ther Med. 2023. PMID: 38125348 Free PMC article.
-
Early Versus Delayed Usage of Paxlovid in Severe Omicron-Infected Patients With Hypoxemia: A Prospective Multiple-Center Cohort Study.Health Sci Rep. 2024 Nov 11;7(11):e70177. doi: 10.1002/hsr2.70177. eCollection 2024 Nov. Health Sci Rep. 2024. PMID: 39534861 Free PMC article.
-
A Systematic Review of Lung Autopsy Findings in Elderly Patients after SARS-CoV-2 Infection.J Clin Med. 2023 Mar 6;12(5):2070. doi: 10.3390/jcm12052070. J Clin Med. 2023. PMID: 36902856 Free PMC article. Review.
-
Antiviral medications for mild-to-moderate COVID-19 in Japan: a gap of timing between clinical trials and real-world scenarios in a fast-changing pandemic.Ann Clin Epidemiol. 2023 Apr 8;5(3):65-73. doi: 10.37737/ace.23009. eCollection 2023. Ann Clin Epidemiol. 2023. PMID: 38504726 Free PMC article.
-
Development and characterization of monoclonal antibodies recognizing nucleocapsid protein of multiple SARS-CoV-2 variants.Heliyon. 2024 Jul 27;10(15):e35325. doi: 10.1016/j.heliyon.2024.e35325. eCollection 2024 Aug 15. Heliyon. 2024. PMID: 39170261 Free PMC article.
References
-
- World Health Organization. [(accessed on 10 December 2022)]. Available online: https://covid19.who.int/table.
-
- Chen X., Wang H., Ai J., Shen L., Lin K., Yuan G., Sheng X., Jin X., Deng Z., Xu J., et al. Identification of CKD, bedridden history and cancer as higher-risk comorbidities and their impact on prognosis of hospitalized Omicron patients: A multicentre cohort study. Emerg. Microbes Infect. 2022;11:2501–2509. doi: 10.1080/22221751.2022.2122581. - DOI - PMC - PubMed
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous